Agena Bioscience Incorporated

Agena Bioscience manufactures the MassARRAY System, a mass spectrometry-based platform for genetic analysis and molecular diagnostics. The company specializes in multiplexed SNP genotyping, mutation detection, and biomarker analysis across multiple clinical and research applications. Primary product lines include pharmacogenetics (PGx) panels such as the VeriDose Core PGx Panel and VeriDose DPYD Plus Panel, oncology mutation profiling panels (lung, colon, melanoma, EGFR), hereditary genetics panels (CFTR 100+, HFE), and custom assay design services. The MassARRAY platform enables liquid biopsy, sample integrity testing, methylation analysis, and specimen validity assessment. Applications span pharmacogenomics, tumor profiling, hereditary disease screening, and precision medicine workflows. Agena operates global distribution through certified service providers and maintains direct sales and support infrastructure across North America, Europe, Asia Pacific, and China. The company provides comprehensive laboratory testing services via Assays by Agena, service plans, and customer support through a dedicated portal. Platform strengths include minimal bioinformatics requirements, broad multiplexing capabilities, cost-effective workflow integration, and compatibility with formalin-fixed paraffin-embedded (FFPE) samples.